Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1982-8-7
pubmed:abstractText
1 Homogenates of mucosa from human colon metabolize [3H]-prostaglandin E1 in the presence of nicotinamide adenine dinucleotide to 15-oxo prostaglandin E1 or 15-oxo, 13,14 dihydro prostaglandin E1. 2 Metabolic capacity of tissue from patients with active ulcerative colitis under treatment with sulphasalazine (0.021 +/- 0.004 nmol/Mg protein +/- s.e. mean) did not differ from mucosa of normal patients (0.02 +/- 0.004 nmol/mg protein) during 1 h incubation. 3 Sulphasalazine inhibits prostaglandin E1 metabolism by mucosal homogenates in a dose-dependent manner with an ID50 of 125 microM. Its therapeutically active metabolite, 5-aminosalicylic acid (2.6 mM) was without significant inhibitory activity. 4 Indomethacin inhibits prostaglandin E1 metabolism by colonic mucosa with an ID50 of 388 microM. 5 At present we cannot clearly relate the therapeutic benefit of sulphasalazine and its therapeutically active metabolite, 5-aminosalicylic acid, in ulcerative colitis to their effects on prostaglandin E synthesis or metabolism in vitro.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-101423, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-13994348, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-14238045, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-30669, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-358989, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-367886, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-40848, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-4854, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-6103724, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-6113614, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-6114012, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-6114307, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-6116944, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-6965522, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-6990725, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-72239, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-7384557, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-7429111, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-7429322, http://linkedlifedata.com/resource/pubmed/commentcorrection/6123357-983858
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
157-61
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't